145 related articles for article (PubMed ID: 32258425)
41. The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE.
Hirst MC; Barnicoat A; Flynn G; Wang Q; Daker M; Buckle VJ; Davies KE; Bobrow M
Hum Mol Genet; 1993 Feb; 2(2):197-200. PubMed ID: 8499907
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.
Crawford DC; Meadows KL; Newman JL; Taft LF; Pettay DL; Gold LB; Hersey SJ; Hinkle EF; Stanfield ML; Holmgreen P; Yeargin-Allsopp M; Boyle C; Sherman SL
Am J Hum Genet; 1999 Feb; 64(2):495-507. PubMed ID: 9973286
[TBL] [Abstract][Full Text] [Related]
43. Frequency of FMR1 premutations in a consecutive newborn population by PCR screening of Guthrie blood spots.
Dawson AJ; Chodirker BN; Chudley AE
Biochem Mol Med; 1995 Oct; 56(1):63-9. PubMed ID: 8593539
[TBL] [Abstract][Full Text] [Related]
44. Microdeletions in FMR2 may be a significant cause of premature ovarian failure.
Murray A; Webb J; Dennis N; Conway G; Morton N
J Med Genet; 1999 Oct; 36(10):767-70. PubMed ID: 10528856
[TBL] [Abstract][Full Text] [Related]
45. Lack of FMR3 expression in a male with non-syndromic mental retardation and a microdeletion immediately distal to FRAXE CCG repeat.
Santos-Rebouças CB; Abdalla CB; Fullston T; Campos M; Pimentel MM; Gécz J
Neurosci Lett; 2006 Apr; 397(3):245-8. PubMed ID: 16469443
[TBL] [Abstract][Full Text] [Related]
46. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
Sharma D; Gupta M; Thelma BK
Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
[TBL] [Abstract][Full Text] [Related]
47. Stability and haplotype analysis of the FRAXE region.
Murray A; Ennis S; Youings SA; Sharrock AJ; Lewis C; Pound MC; Macpherson JN; Dennis NR; Morton NE; Jacobs PA
Eur J Hum Genet; 2000 Aug; 8(8):583-9. PubMed ID: 10951520
[TBL] [Abstract][Full Text] [Related]
48. Fragile X founder effects and new mutations in Finland.
Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
[TBL] [Abstract][Full Text] [Related]
49. A rapid, non-radioactive screening test for fragile X mutations at the FRAXA and FRAXE loci.
Wang Q; Green E; Bobrow M; Mathew CG
J Med Genet; 1995 Mar; 32(3):170-3. PubMed ID: 7783163
[TBL] [Abstract][Full Text] [Related]
50. The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter.
Ritchie RJ; Knight SJ; Hirst MC; Grewal PK; Bobrow M; Cross GS; Davies KE
Hum Mol Genet; 1994 Dec; 3(12):2115-21. PubMed ID: 7881407
[TBL] [Abstract][Full Text] [Related]
51. FMR2 function: insight from a mouse knockout model.
Gu Y; Nelson DL
Cytogenet Genome Res; 2003; 100(1-4):129-39. PubMed ID: 14526173
[TBL] [Abstract][Full Text] [Related]
52. FRAXE mutation analysis in three Spanish families.
Carbonell P; López I; Gabarrón J; Bernabé MJ; Lucas JM; Guitart M; Gabau E; Glover G
Am J Med Genet; 1996 Aug; 64(2):434-40. PubMed ID: 8844099
[TBL] [Abstract][Full Text] [Related]
53. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
54. A high-density SNP map for the FRAX region of the X chromosome. Single-nucleotide polymorphisms.
Brightwell G; Wycherley R; Potts G; Waghorn A
J Hum Genet; 2002; 47(11):567-75. PubMed ID: 12436192
[TBL] [Abstract][Full Text] [Related]
55. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.
Knight SJ; Flannery AV; Hirst MC; Campbell L; Christodoulou Z; Phelps SR; Pointon J; Middleton-Price HR; Barnicoat A; Pembrey ME
Cell; 1993 Jul; 74(1):127-34. PubMed ID: 8334699
[TBL] [Abstract][Full Text] [Related]
56. FRAXE expansion is not a common etiological factor among developmentally delayed males.
Allingham-Hawkins DJ; Ray PN
Am J Hum Genet; 1995 Jul; 57(1):72-6. PubMed ID: 7541938
[TBL] [Abstract][Full Text] [Related]
57. Lack of expansion of triplet repeats in the FMR1, FRAXE, and FRAXF loci in male multiplex families with autism and pervasive developmental disorders.
Holden JJ; Wing M; Chalifoux M; Julien-Inalsingh C; Schutz C; Robinson P; Szatmari P; White BN
Am J Med Genet; 1996 Aug; 64(2):399-403. PubMed ID: 8844091
[TBL] [Abstract][Full Text] [Related]
58. FRAXE and mental retardation.
Mulley JC; Yu S; Loesch DZ; Hay DA; Donnelly A; Gedeon AK; Carbonell P; López I; Glover G; Gabarrón I
J Med Genet; 1995 Mar; 32(3):162-9. PubMed ID: 7783162
[TBL] [Abstract][Full Text] [Related]
59. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
Pandey UB; Phadke S; Mittal B
Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
[TBL] [Abstract][Full Text] [Related]
60. Possible founder effects for FRAXE alleles.
Limprasert P; Zhong N; Currie JR; Brown WT
Am J Med Genet; 1999 May; 84(3):286-90. PubMed ID: 10331609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
